According to IMARC Group’s latest report, titled “Negative Pressure Wound Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global negative pressure wound therapy market size reached US$ 2,510.0 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 3,419.8 Million by 2027, exhibiting a growth rate (CAGR) of 5.2% during 2022-2027.
The negative pressure wound therapy (NPWT), also known as vacuum-assisted closure, is a therapeutic technique for treating chronic wounds, infections, and burns. The treatment connects a vacuum dressing to a pump for creating negative pressure around the wound, thereby increasing the blood flow, and drawing out excess fluid. NPWT also aids in granulation tissue formation and wound contraction while minimizing edema and preventing infections. As a result, this therapy is used for treating diabetic ulcers, pressure ulcers, skin flaps, grafts, etc.
Request For a Free PDF Sample Report: https://www.imarcgroup.com/negative-pressure-wound-therapy-market/requestsample
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
Negative Pressure Wound Therapy Market:
The rising incidences of diabetes mellitus, which often causes arterial and diabetic foot ulcers, are treated using NPWT devices. Furthermore, the growing geriatric population also increases the risks of diabetic wounds and other infections, thereby propelling the need for efficient medical procedures. Moreover, the development of technologically advanced disposable NPWT devices, with high portability and cost-effectiveness, has fostered the market growth. The rising adoption of these devices can be used for providing healthcare at home, thereby eliminating the need for prolonged hospital stays and mitigating the risks of hospital-acquired infections (HAIs). Additionally, the introduction of multi-wound NPWT devices, along with rapid integration with dynamic pressure control and leak detection systems, are also bolstering the market growth. In the coming years, the rising investments in healthcare infrastructure development are further expected to proliferate the negative pressure wound therapy (NPWT) market.
Competitive Landscape with Key Players:
The competitive landscape of the industry has also been examined with some of the key players.
- Cardinal Health Inc.
- Carilex Medical Inc.
- ConvaTec Group PLC
- Genadyne Biotechnologies Inc.
- Lohmann & Rauscher International GmbH & Co. Kg
- Mölnlycke Health Care AB (A Subsidiary of Investor AB)
- Smith & Nephew
- Talley Group
Explore full report with TOC & List of Figures: https://bit.ly/3WazTbn
Key Market Segmentation:
The report has categorized the market based on device, component, wound type, indication and end-user.
Breakup by Device:
- Conventional NPWT Devices
- Single-use NPWT Devices
Breakup by Component:
- Canisters and Dressings
Breakup by Wound Type:
- Chronic Wounds
- Acute Wounds
Breakup by Indication:
- Surgical and Traumatic Wounds
- Pressure Ulcers
- Venous Ulcers
- Diabetic Foot Ulcer
Breakup by End-User:
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Home Care Settings
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800